US FDA approves Mesoblast’s cell therapy for graft-versus-host disease
(Reuters) – The U.S. Food and Drug Administration on Wednesday approved Mesoblast (NASDAQ:MESO)’s cell therapy for treating a type of complication that
(Reuters) – The U.S. Food and Drug Administration on Wednesday approved Mesoblast (NASDAQ:MESO)’s cell therapy for treating a type of complication that
(Reuters) – Australia’s Champion Iron said on Thursday Japanese firms Nippon Steel and Sojitz will take up a 49% stake for A$245
Investing.com– Air conditioning maker Lennox International Inc (NYSE:LII) will join the S&P 500 from next week, S&P Dow Jones Indices
IRVINE, Calif. – The co-founders of WM Technology, Inc., better known as Weedmaps, have approached the company’s board with a proposal to
(Reuters) – ANZ Group’s CEO Shayne Elliott will not be taking the 2024 long-term variable remuneration after a large proportion of shareholders
By Greg Bensinger (Reuters) – Pressure is building on Amazon.com (NASDAQ:AMZN) to come to the bargaining table with the Teamsters union as thousands
By Amina Niasse NEW YORK (Reuters) -U.S. healthcare spending rose by 7.5% to $4.9 trillion in 2023, driven by increased use of medical
Tesla (NASDAQ:TSLA) shares tumbled 8.3% Wednesday as U.S. stocks fell broadly in response to the Federal Reserve’s latest policy commentary. NVIDIA (NASDAQ:NVDA)
WASHINGTON (Reuters) – The U.S. said on Wednesday it has requested the establishment of dispute settlement panels under the U.S.-Mexico-Canada trade deal
Investing.com – Colombia stocks were lower after the close on Wednesday, as losses in the Financials, Investment and Public Services sectors led